Explain the envy ratio and sweet equity in a management equity package, and what they tell you about alignment.
An advanced Private Equity question — expect it in final rounds and case-heavy interviews (IB, PE, Big-4 Transaction Services).
THE SHORT ANSWER
In a buyout, management typically invests alongside the sponsor but on terms that give them disproportionate upside if the deal succeeds — 'sweet equity'. The envy ratio measures this: it's the effective price the sponsor pays per share of ordinary equity relative to the price management pays, i.e., how much more the institution pays for the same ordinary equity. A higher envy ratio means management gets their ordinary (sweet) equity cheaply relative to the sponsor, who funds most of the structure through shareholder loans/preference shares that rank ahead. The structure aligns incentives: management's sweet equity is geared, so they only make real money once the sponsor's loan/preference is repaid and a return cleared — strong upside for outperformance, but they're junior, so a mediocre outcome leaves them with little. It tells you how aggressively management is incentivized and how the value splits.
WHAT INTERVIEWERS LISTEN FOR
- ✓Sweet equity = management's geared ordinary equity on favorable terms
- ✓Envy ratio = sponsor's per-share price ÷ management's per-share price
- ✓Sponsor funds via shareholder loans/prefs ranking ahead
- ✓Aligns incentives: management win only after sponsor return cleared
COMMON MISTAKES
- ✗Confusing sweet equity with a plain co-invest
- ✗Not knowing what the envy ratio measures
- ✗Ignoring the ranking of shareholder loans/prefs
Reading isn't the same as answering under pressure.
Interviewers don't hand you the model answer — you deliver yours on a clock. Practice this and 1,000+ questions with AI feedback on every answer.
RELATED QUESTIONS
- How do you handle a covenant breach?
- How would you assess a carve-out opportunity for PE?
- When would you use PIK (Payment-in-Kind) debt?
- What's the difference between an equity cure and a capital injection?
- How do PE firms handle underperforming portfolio companies?
- How does a PE fund handle currency risk in cross-border deals?